Butyrylcholinesterase K variant and cerebral amyloid angiopathy

Stroke

Volumn 29, Issue 12, 1998, Pages 2488-2490

  Yamada, Masahito ^a   Sodeyama, Nobuyuki ^a   Itoh, Yoshinori ^b   Suematsu, Naomi ^b   Otomo, Eiichi ^b   Matsushita, Masaaki ^c   Mizusawa, Hidehiro ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b Yokufukai Geriatric Hospital   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

Alzheimer's disease; Amyloid; Cerebrovascular disorders; Elderly; Polymorphism (genetics)

Indexed keywords

APOLIPOPROTEIN E4; CHOLINESTERASE; ENZYME VARIANT;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; CONTROLLED STUDY; DISEASE SEVERITY; GENETIC RISK; GENOTYPE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; VASCULAR AMYLOIDOSIS;

EID: 0031756084     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.29.12.2488     Document Type: Article

References (23)

1. Vinters HV. Cerebral amyloid angiopathy: a critical review. Stroke. 1987; 18:311-324.
2. Yamada M, Tsukagoshi H, Otomo E, Hayakawa M. Cerebral amyloid angiopathy in the aged. J Neurol. 1987;234:371-376.
3. Itoh Y, Yamada M, Hayakawa M, Otomo E, Miyalake T. Cerebral amyloid angiopathy: a significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderly. J Neurol Sci. 1993;116:135-141.
4. Greenberg SG, Rebeck GW, Vonsattel JPG, Gomez-Isla T, Hyman BT. Apolipoprotein E ε4 and cerebral hemorrhage associated with amyloid angiopathy. Ann Neurol. 1995;38:254-259.
5. Premkumar DRD, Cohen DL, Hedera P, Friedland RP, Kalaria RN. Apolipoprotein E ε4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am J Pathol. 1996;148:2083-2095.
6. Itoh Y, Yamada M, Suematsu N, Matsushita M, Otomo E. Influence of apolipoprotein E genotype on cerebral amyloid angiopathy in the elderly. Stroke. 1996;27:216-218.
7. Yamada M, Itoh Y, Suematsu N, Matsushita M, Otomo E. Lack of an association between apolipoprotein E ε4 and cerebral amyloid angiopathy in elderly Japanese. Ann Neurol. 1996;39:683. Letter.
8. Nicoll JAR, Burnett C, Love S, Graham DI, Dewar D, Ironside JW, Steward J, Vinters HV. High frequency of apolipoprotein E ε2 in hemorrhage due to cerebral amyloid angiopathy. Ann Neurol. 1997;41:716-721.
9. Yamada M, Sodeyama N, Itoh Y, Suematsu N, Otomo E, Matsushita M, Mizusawa H. Association of presenilin-1 polymorphism with cerebral amyloid angiopathy in the elderly. Stroke. 1997;28:2219-2221.
10. Yamada M, Sodeyama N, Itoh Y, Suematsu N, Otomo E, Matsushita M, Mizusawa H. Association of α1-antichymotrypsin polymorphism with cerebral amyloid angiopathy. Ann Neurol. 1998;44:129-131.
11. Mesulam M, Carson K, Price B, Geula C. Cholinesterases in the amyloid angiopathy of Alzheimer's disease. Ann Neurol. 1992;31:565-569.
12. Mesulam MM, Geula C. Butyrylcholinesterase reactivity differentiates the amyloid plaques of aging from those of dementia. Ann Neurol. 1994;36:722-727.
13. Moran MA, Mufson EJ, Gómez-Ramos P. Colocalization of cholinesterases with β amyloid protein in aged and Alzheimer's brains. Acta Neuropathol (Berl). 1993;85:362-369.
14. Geula C, Mesulam MM. Cholinesterases and the pathology of Alzheimer disease. Alzheimer Dis Assoc Disord. 1995;9(suppl 2):23-28.
15. Inestrosa NC, Alvarez A, Pérez CA, Moreno D, Vicente M, Linker C, Casanueva OI, Soto C, Garrido J. Acetylcholinesterase accelerates assembly of amyloid-β-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme. Neuron. 1996;16:881-891.
16. Perry EK. The cholinergic system in old age and Alzheimer's disease. Age Aging. 1980;9:1-8.
17. Bartels CF, Jensen FS, Lockridge O, van der Spek AFL, Rubinstein HM, Lubrano T, La Du BN. DNA mutation associated with the human butyrylcholinesterase K-variant and its linkage to the atypical variant mutation and other polymorphic sites. Am J Hum Genet. 1992;50:1086-1103.
18. Minor DL, Kim PS. Measurement of the β-sheet-forming propensities of amino acids. Nature. 1994;367:660-663.
19. Pepys MB, Hawkins PN, Brooth DR, Vigushin DM, Tennent GA, Soutar AK, Totty N, Nguyen O, Blake CCF, Terry CJ, Feest TG, Zalin AM, Hsuan JJ. Human lysozyme gene mutations cause hereditary systemic amyloidosis. Nature. 1993;362:553-557.
20. Lehmann DJ, Johnston C, Smith AD. Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer's disease. Hum Mol Genet. 1997;6:1933-1936.
21. Mirra S, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L, Participating CERAD Neuropathologists. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), part II: standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 1991;41:479-486.
22. Jensen FS, Nielsen LR, Schwartz M. Detection of the plasma cholinesterase K variant by PCR using an amplification-created restriction site. Hum Hered. 1996;46:26-31.
23. Sigleton AB, Smith G, Gibson AM, Woodward R, Perry RH, Ince PG, Edwardson JA, Morris CM. No association between the K variant of the butyrylcholinesterase gene and pathologically confirmed Alzheimer's disease. Hum Mol Genet. 1998;7:937-939.